TRANSURETHRAL MICROWAVE THERMOTHERAPY IN THE TREATMENT OF BENIGN PROSTATIC HYPERPLASIA - RESULTS OBTAINED WITH THE UROLOGIX T3 DEVICE

The objective of this study was to assess the efficacy and safety of a new transurethral microwave thermotherapy device, T3, in the treatmen t of symptomatic benign prostatic hyperplasia. A total of 155 patients were recruited at 3 sites and treated using an identical protocol. Th e mean AUA symptom score decreased by 58% at 12 months, by 61% at 34 m onths and by 56% at 36 months. The increase in mean peak How rates at these time points was 3.9 (47%), 3.4 (44%) and 5.1 ml/s (67%), respect ively. Adverse events were minor and the patients' satisfaction with t reatment was high. Transurethral microwave thermotherapy with the T3 d evice provides a safe. effective treatment for symptomatic benign pros tatic hyperplasia.